• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Medisafe Launches New Platform for Medication Management to Improve Patient Journey

Share:

September 16, 2020

Highlights on this story:
  • Medisafe launches a new Medisafe Maestro platform that brings precision and speed to patient journeys.
  • The new platform aims to revolutionize digital health platforms by combining a host of resources to help patients through any hurdle in their journey and updates and monitoring happen in real-time to meet patients in their moments.

Medisafe, a Boston, MA-based digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform. This advanced technology seamlessly orchestrates medication adherence journeys with precision and speed, creating personalized patient support resources delivered through a digital drug companion. Medisafe supports the pharmaceutical ecosystem with digital patient support resources through its personalized digital drug companion and integrated Care Connector which activates real-time patient engagement.

Supporting patients across their unique treatment needs requires a coordinated approach with tailored interventions and specific resources to meet patients in their moments. Medisafe Maestro fosters collaboration with partners to build adaptive patient journeys that address individual challenges, providing personalized support to navigate through any roadblocks to continue treatment. With every patient behavior, Medisafe Maestro continuously optimizes the journey, incorporating elements such as patient education, clinician guidance, guided treatment videos, financial support awareness and includes family, friends, and caregivers into treatment.

Orchestrated Approach to Digital Medication Management Journeys

Medisafe Maestro increases the speed to market with its advanced functionality, such as:

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Central Command Center to manage the creation and collaboration of digital drug companions that digitize patient support programs.

– Interactive Flow Mapping to design the inventory of supportive content, including rules and intervention deployment, and an archive of creative images and brand style.

– Intuitive step-by-step build that processes and delivers concurrent, sequential, and exception-based patient support tools.

– Compliance Oversight that aligns business goals with ISI display configuration and Medical Legal Regularity (MLR) review.

– Real-time Visibility provides insights into patient journeys.

“The introduction of Medisafe Maestro aims to revolutionize digital health platforms by enhancing the speed and agility in developing and deploying branded patient resources, bolstering treatment adherence, and improving patient outcomes,” said Omri Shor, Medisafe Chief Executive Officer. “Optimizing patient journeys requires hundreds or thousands of modifications that can impact a patient, creating challenges or roadblocks to successful treatment. Until now, this often meant starting from scratch with every patient flow process for drug partners. But Medisafe Maestro has done all of the heavy lifting, advancing innovation with enhanced patient support engagement.”

Availability

The company has already implemented the system for several partners who praised the increased functionality and faster build time, including its agile environment and ease of use.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Tekscan Acquired by ArtemisTekscan Acquired by Artemis
  • “Organism Company” Ginkgo Bioworks Lands Massive SPAC Deal“Organism Company” Ginkgo Bioworks Lands Massive SPAC Deal
  • HIT execs affirm medical devices grow as security risksHIT execs affirm medical devices grow as security risks
  • Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product PortfolioBruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
  • Spanish Mobile Network Yoigo Launches Telemedicine Service Doctor GoSpanish Mobile Network Yoigo Launches Telemedicine Service Doctor Go
  • Ada Health Secures $90M Series B Funding to Advance Health Assessment TechnologyAda Health Secures $90M Series B Funding to Advance Health Assessment Technology
  • Blurring of lines between medicines and medical devices is confusing authorisation process, MHRA warnsBlurring of lines between medicines and medical devices is confusing authorisation process, MHRA warns
  • Maximizing Telehealth Success: How to Optimize Operations & Revenue Cycle ManagementMaximizing Telehealth Success: How to Optimize Operations & Revenue Cycle Management

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications